phase 1
study 1
cladribine 1
cytarabine 1
arac 1
granulocyte 1
colony 1
stimulating 1
factor 1
gcsf 1
clag 1
regimen 1
simultaneous 1
escalating 1
doses 1
imatinib 1
mesylate 1
gleevec 1
relapsedrefractory 1
aml 1
profound 1
hypogammaglobulinemia 1
years 1
treatment 1
indolent 1
lymphoma 1
